Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Biochemical endothelial markers and cardiovascular remodeling in refractory arterial hypertension
Author: Cittadino, M
de Sousa, MG
Yugar-Toledo, JC
Rocha, JC
Tanus-Santos, JE
Moreno, H
Abstract: Background. Hypertension is the most important and well established risk factor for atherosclerosis. The vascular and cardiac remodeling present in refractory hypertensive patients are related to endothelial dysfunction, a key factor in early atherogenesis and cardiovascular disease. However the mechanistic relationship among biochemical endothelial function markers, cardiovascular remodeling, and refractory hypertension is unknown. Methods. We evaluated the left ventricular mass and function, carotid thickness, and plasma nitrate/nitrite (NO2/NO3) cyclic 3'-5'-guanosine monophosphate (cGMP), and thromboxane B-2 (TXB2) levels in refractory hypertensive (RH; n = 20) and healthy (CONTROL; n = 20) subjects 22-65 years old. Carotid thickness, left ventricular mass index (LVMI), and left ventricular fraction ejection (LVFE) were estimated by duplex scan ultrasound. Nitrates/nitrites were assayed using the Griess reaction, and plasma cGMP and thromboxane B-2 were determined by enzymatic immunoassay (EIA). Results. Left ventricular mass index was higher in the RH group (138 +/- 20 vs. 108 +/- 17 g/m(2), p < 0.001) but there was no significant difference in the ejection fraction (67 +/- 5% vs. 69 +/- 4%). Pulse pressure (61 +/- 9mmHg vs. 46 +/- 10mmHg) and carotid thickness (1.59 +/- 0.22mm vs. 1.04 +/- 0.14mm) were significantly higher (p<0.001) in RH patients whereas NO2/NO3, cGMP, and thromboxane B-2 plasma concentrations were similar in both groups. Conclusion. There was no association between cardiovascular remodeling and die particular biochemical markers of endothelial function we assessed in refractory hypertensive patients.
Subject: resistant hypertension
cardiac hypertrophy
pulse pressure
thromboxane B-2
Country: EUA
Editor: Marcel Dekker Inc
Citation: Clinical And Experimental Hypertension. Marcel Dekker Inc, v. 25, n. 1, n. 25, n. 33, 2003.
Rights: fechado
Identifier DOI: 10.1081/CEH-120017738
Date Issue: 2003
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000180949300003.pdf124.61 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.